LJL BIOSYSTEMS
LJL is developing and marketing proprietary technologies and products to accelerate and enhance the drug discovery process. LJL's proprietary integrated technology platform is comprised of instrumentation and fluorescence-based and other assay technologies designed to provide a flexible solution to the current and evolving HTS requirements of drug discovery laboratories. The drug discovery process involves several stages including target identification, compound synthesis, assay development, screening and lead optimization.
LJL BIOSYSTEMS
Industry:
Biotechnology Information Technology Product Design
Founded:
1988-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
0
Current Advisors List
Current Employees Featured
Stock Details
Company's stock symbol is NASDAQ:LJLB
Investors List
Bay City Capital
Bay City Capital investment in Post-IPO Equity - LJL Biosystems